Trading Symbol
DESIFARMS
Key Details of Delay
- A Board of Directors meeting was previously rescheduled to be held on Wednesday, June 10, 2026, to consider and approve the results.
- The company is unable to finalize the results due to two primary reasons:
1. Pending receipt of certain information and supporting documents.
2. Additional time required for verification and review of necessary financial data.
- A significant factor contributing to the delay is a change in management that occurred during the financial year. This change has necessitated a comprehensive review of various financial and operational records to ensure accuracy, completeness, and regulatory compliance.
Forward Plan & Commitments
- The company is making all necessary efforts to complete the review process at the earliest.
- A meeting of the Board of Directors will be convened immediately upon completion of the exercise to consider and approve the Audited Financial Results.
- The revised date for this board meeting will be intimated to the stock exchanges in due course.
- The company regrets the delay and assures stakeholders of its commitment to the highest standards of corporate governance, transparency, and regulatory compliance.
Financial Impact
Financial impact is not quantified in the disclosure. The disclosure pertains to a timing delay rather than a specific financial result.